J0219 HCPCS code: Injection, avalglucosidase alfa-ngpt, 4 mg
J0219 is the HCPCS Level II code for injection, avalglucosidase alfa-ngpt, 4 mg. In 2024 Medicare paid an average of $59.75 per service for J0219 across 290,003 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 750 per day on outpatient hospital claims. Medicare volume rose 140% from 2022 to 2024 (120,762 to 290,003 services). In 2024, about 91 clinicians billed Medicare for J0219 for 36 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-04-01 |
| Last action effective | 2022-04-01 |
Who bills J0219 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 91 |
| Medicare beneficiaries | 36 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0219, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 120,762 | 24 | $72.59 | $57.86 |
| 2023 | 268,911 | 30 | $72.70 | $57.91 |
| 2024 | 290,003 | 36 | $75.00 | $59.75 |
States with the most J0219 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 109,473 | $60.21 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 750 | Prescribing Information |
| practitioner claims | 750 | Prescribing Information |
What changed for J0219
- 2022-04-01: J0219 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0219?
J0219 is the HCPCS Level II code for injection, avalglucosidase alfa-ngpt, 4 mg. Short descriptor: "Inj aval alfa-nqpt 4mg".
How much does Medicare pay for J0219?
In 2024, the average Medicare payment was $59.75 per service (average allowed $75.00).
Does Medicare cover J0219?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0219 can be billed per day?
750 on outpatient hospital claims; 750 on practitioner claims (NCCI medically unlikely edits).
Related J02 codes
- J0200 — Injection, alatrofloxacin mesylate, 100 mg
- J0202 — Injection, alemtuzumab, 1 mg
- J0205 — Injection, alglucerase, per 10 units
- J0206 — Injection, allopurinol sodium, 1 mg
- J0207 — Injection, amifostine, 500 mg
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
- J0209 — Injection, sodium thiosulfate (hope), 100 mg
- J0210 — Injection, methyldopate hcl, up to 250 mg
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215 — Injection, alefacept, 0.5 mg
- J0216 — Injection, alfentanil hydrochloride, 500 micrograms
- J0217 — Injection, velmanase alfa-tycv, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0219
- Watch J0219 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0219
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.